BACKGROUND: African Americans are consistently underrepresented in cancer clinical trials. Minority under-enrolment may be, in part, due to differences in the way clinical trials are discussed in oncology visits with African American vs. White patients. OBJECTIVE: To investigate differences in oncologist-patient communication during offers to participate in clinical trials in oncology visits with African American and White patients. METHODS: From an archive of video-recorded oncology visits, we selected all visits with African American patients that included a trial offer (n = 11) and a matched sample of visits with demographically/medically comparable White patients (n = 11). Using mixed qualitative-quantitative methods, we assessed differences by patient race in (i) word count of entire visits and (ii) frequency of mentions and word count of discussions of clinical trials and key elements of consent. RESULTS: Visits with African American patients, compared to visits with White patients, were shorter overall and included fewer mentions of and less discussion of clinical trials. Also, visits with African Americans included less discussion of the purpose and risks of trials offered, but more discussion of voluntary participation. DISCUSSION AND CONCLUSIONS: African American patients may make decisions about clinical trial participation based on less discussion with oncologists than do White patients. Possible explanations include a less active communication style of African Americans in medical visits, oncologists' concerns about patient mistrust, and/or oncologist racial bias. Findings suggest oncologists should pay more conscious attention to developing the topic of clinical trials with African American patients, particularly purpose and risks.
BACKGROUND: African Americans are consistently underrepresented in cancer clinical trials. Minority under-enrolment may be, in part, due to differences in the way clinical trials are discussed in oncology visits with African American vs. White patients. OBJECTIVE: To investigate differences in oncologist-patient communication during offers to participate in clinical trials in oncology visits with African American and White patients. METHODS: From an archive of video-recorded oncology visits, we selected all visits with African American patients that included a trial offer (n = 11) and a matched sample of visits with demographically/medically comparable White patients (n = 11). Using mixed qualitative-quantitative methods, we assessed differences by patient race in (i) word count of entire visits and (ii) frequency of mentions and word count of discussions of clinical trials and key elements of consent. RESULTS: Visits with African American patients, compared to visits with White patients, were shorter overall and included fewer mentions of and less discussion of clinical trials. Also, visits with African Americans included less discussion of the purpose and risks of trials offered, but more discussion of voluntary participation. DISCUSSION AND CONCLUSIONS: African American patients may make decisions about clinical trial participation based on less discussion with oncologists than do White patients. Possible explanations include a less active communication style of African Americans in medical visits, oncologists' concerns about patient mistrust, and/or oncologist racial bias. Findings suggest oncologists should pay more conscious attention to developing the topic of clinical trials with African American patients, particularly purpose and risks.
Authors: Mollie W Howerton; M Chris Gibbons; Charles R Baffi; Tiffany L Gary; Gabriel Y Lai; Shari Bolen; Jon Tilburt; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass; Jean G Ford Journal: Cancer Date: 2007-02-01 Impact factor: 6.860
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Louis A Penner; John F Dovidio; Tessa V West; Samuel L Gaertner; Terrance L Albrecht; Rhonda K Dailey; Tsveti Markova Journal: J Exp Soc Psychol Date: 2010-03-01
Authors: Chanita Hughes Halbert; Benita Weathers; Ernestine Delmoor; Brandon Mahler; James Coyne; Hayley S Thompson; Thomas Ten Have; David Vaughn; S Bruce Malkowicz; David Lee Journal: Cancer Date: 2009-06-01 Impact factor: 6.860
Authors: Stephanie L Pugh; Joseph P Rodgers; Katherine A Yeager; Ronald C Chen; Benjamin Movsas; Roseann Bonanni; James Dignam; Deborah W Bruner Journal: Int J Radiat Oncol Biol Phys Date: 2020-06-24 Impact factor: 7.038
Authors: Lauren M Hamel; Robert Chapman; Mary Malloy; Susan Eggly; Louis A Penner; Anthony F Shields; Michael S Simon; Justin F Klamerus; Charles Schiffer; Terrence L Albrecht Journal: J Clin Oncol Date: 2015-09-21 Impact factor: 44.544
Authors: Susan Eggly; Lauren M Hamel; Tanina S Foster; Terrance L Albrecht; Robert Chapman; Felicity W K Harper; Hayley Thompson; Jennifer J Griggs; Richard Gonzalez; Lisa Berry-Bobovski; Rifky Tkatch; Michael Simon; Anthony Shields; Shirish Gadgeel; Randa Loutfi; Haythem Ali; Ira Wollner; Louis A Penner Journal: Patient Educ Couns Date: 2016-12-27
Authors: Megan Johnson Shen; Emily B Peterson; Rosario Costas-Muñiz; Migda Hunter Hernandez; Sarah T Jewell; Konstantina Matsoukas; Carma L Bylund Journal: J Racial Ethn Health Disparities Date: 2017-03-08
Authors: Anita Kurt; Lauren Semler; Matthew Meyers; Bernadette G Porter; Jeanne L Jacoby; Brian Stello Journal: J Racial Ethn Health Disparities Date: 2016-12-21
Authors: Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly Journal: Cancer Control Date: 2016-10 Impact factor: 3.302
Authors: Susan Eggly; Rifky Tkatch; Louis A Penner; Lorna Mabunda; Janella Hudson; Robert Chapman; Jennifer J Griggs; Richard Brown; Terrance Albrecht Journal: J Cancer Educ Date: 2013-06 Impact factor: 2.037